Navigation Links
Introducing D-Psoria, the First Cosmeceutical Products for the Relief of the Redness, Scaling, and Flaking of Severely Damaged Skin

Ayurvedic science-based products from MediNiche provide alternative natural relief prior to considering drugs.

St. Louis, MO (PRWEB) December 17, 2009 -- D-Psoria products are the first topical, non-prescription cosmeceuticals for the redness, scaling and flaking associated with severe skin conditions. Developed by Astrel Genome Ltd., D-Psoria is being marketed in the U.S. by MediNiche Pharmaceuticals, St. Louis, Missouri.

D-Psoria products were developed in conjunction with doctors, estheticians and ayurvedic (science of life) natural principles. All products utilize natural ingredients, unique herbal extracts and key minerals, that when applied topically are designed specifically to help regenerate new, healthy skin.

D-Psoria is ideal for use by patients and consumers that wish to try a natural product as an alternative prior to considering prescription drug therapy. It is being promoted to medical and skincare professionals for recommendation to patients and consumers as a pre-pharmacotherapy consideration.

MediNiche believes D-Psoria to gain rapid acceptance among dermatologists, estheticians and skincare professionals through trial and end user satisfaction. According to Sunny Desai, MD of St. Louis MO, “D-Psoria should help provide relief to patients with severely damaged skin due to the excellent clinically proven characteristics such as the regeneration of new, healthy skin and because it does not erase the memory of T-cells; thus, minimizing effect on the immune system. In addition, D-Psoria does not contain corticosteroids or any drugs, coal tar or pine tar, salicylic acid, parabens or immunosuppressants which can cause unwanted skin sensitization, allergic reaction or rebound effects.”

Rosann Breen, an esthetician at Howard’s Salon in Pittsburgh, PA and a forty (40) year veteran of professional skincare service, states “We are very excited to have D-Psoria available for our customers with severely damaged skin. In the past, most cosmeceutical products that we had in our offering for tough skin conditions were not very helpful in providing relief. Many customers would seek medical care and begin prescription drug therapies. D-Psoria has been a wonderful new option for my customers that need real help and want to try alternatives before initiating drug therapy”. Ms. Breen receives significant feedback from her clientele on the benefits of D-Psoria, “Rarely have I used and recommended a product that draws such immediate positive comment from customers. It’s unusual if I do not hear back within a week about the fantastic relief that D-Psoria provided.”

D-Psoria is available in three (3) package styles; cream (3.52 oz. tube), shampoo (5.3 oz. bottle), and a combo-pack containing both the cream and shampoo packaged together. The combo-pack was developed for people with severe skin conditions that typically present with both skin and scalp redness, scaling and flaking. D-Psoria cream and shampoo 50 ml. trial sizes are also available.

Introductory wholesale and retail trade stocking programs are available from MediNiche. Suggested retail selling pricing for D-Psoria cream and D-Psoria shampoo is $25 per package and $40 for the D-Psoria combo-pack.

D-Psoria can be purchased for home delivery by calling MediNiche, toll-free, at 888-325-2395 or on the Internet by visiting and for pick up at a local Wal-Mart store. D-Psoria will also be available on the shelves of traditional retail trade outlets such as drug, food and discount stores in the near future.

Samuel Alioto, President and CEO of MediNiche states, “People with severe and harshly damaged skin want relief ---relief that lasts. Most have tried multiple products and regimens with some short term success.
D-Psoria provides a chance for them to have a more sustained, longer term positive result. We are excited to get D-Psoria in the hands of people that can benefit from its use.”

MediNiche: Innovative Products for Professional Recommendation

MediNiche, Inc. is a St. Louis based pharmaceutical company that develops, markets and distributes dermatologic, ob/gyn, internal medicine, orthopedic, ophthalmic and dental products. MediNiche markets OCUDERMA, ocular skin therapy gel, and ORTHO.TABS, vitamin and mineral supplement for bone health, DENTAPLEX, vitamin and mineral supplement for oral health, D-PSORIA, cosmeceuticals for severe skin conditions, UROVITE, dietary supplement for prostate health, VIVA-DROPS, preservative-free lubricant eye drops, TRANSITIA, dietary supplement to help transition through hormonal change and VASOVITE, dietary supplement for vascular health. MediNiche is pursuing additional new products through internal development, partnerships and collaborations.

Contact: Samuel Alioto, MediNiche, Inc., - (314) 542-9539, 888-325-2395


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Video: Introducing Natural Acne Solutions(TM) By Burts Bees(R)
2. Introducing Sore Throat Relief Parents Trust in a Form that Fizzles!
3. Barry Bloom, Jeffrey Sachs to Be Honored for Introducing Modern Solutions to The Worlds Oldest Problems: Poverty And Disease
4. Cost Effective Solution for Patient Testing: Introducing Comprehensive and Affordable Molecular Diagnosis With Verifiable Accuracy
5. Introducing anuleaf AD, a New FDA-Approved Hemorrhoid Treatment
6. Introducing All-New IEHP Superhero to Battle Childhood Obesity
7. Introducing Healthspottr: The New Voice of Healthcare Innovation
8. Improving the science of systematic reviews: Introducing the PRISMA statement
9. U.S. Debut: Holistic Health And Beauty From The Rainforest - New Book Reveals Closely Guarded Malaysian Health and Beauty Secrets Introducing the World to Time-Honored Tradition of Ramuan
10. Oral and Maxillofacial Surgeons Applaud Senator Mary Landrieu (D-LA) For Introducing Legislation to Require Insurance Coverage for Children With Congenital Deformities
11. Introducing COPPERTONE(R) NutraShield(R) With Dual Defense(R), New Sunscreen Line With Antioxidants To Help Promote Natural Skin Repair
Post Your Comments:
Related Image:
Introducing D-Psoria, the First Cosmeceutical Products for the Relief of the Redness, Scaling, and Flaking of Severely Damaged Skin
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... Dental Association meeting in Washington D.C. revolved around the fact that proper dental care, ... The talk stressed the link between periodontal disease (more commonly referred to as gum ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... and convenient way to dispense prescription medications at home, so he invented the ... to monitor and dispense prescription medications. In doing so, it could help to ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that ... ). More than 3.7 billion people under the age of 50 – or 67% ... WHO's first global estimates of HSV-1 infection . , "The data shocks us highly!" ...
(Date:11/27/2015)... ... 2015 , ... Keeping in mind challenges faced by parents ... consultation, has collaborated with a leading web-based marketplace for extra-curricular activities for children ... and bring advice from parenting experts within their reach. As a part of ...
(Date:11/27/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk ... Term Support) into its Q-Suite 5.10 product line. , Making the change to ... of Asterisk that will receive not only security fixes, but feature and bug ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... WASHINGTON , Nov. 25, 2015  The ... Obstetricians and Gynecologists (ACOG), and the March of ... bipartisan Protecting Our Infants Act of 2015 ... the number of newborns born exposed to drugs, ... Since the bill,s introduction, all three organizations have ...
(Date:11/25/2015)... Nov. 25, 2015 On Tuesday, November ... bellwether trial against Wright Medical Technology, Inc. for ... Conserve metal-on-metal hip implant device, awarded $11 million ... two week trial and three days of deliberations, ... device was defectively designed and unreasonably dangerous, and ...
(Date:11/25/2015)... Israel , November 25, 2015 ... KTOV ) (TASE: KTOV), a biopharmaceutical company focused ... treatment of various clinical conditions, today announced the closing ... American Depository Shares ( ADSs ), each representing 20 ... up to 3,158,900 ADSs. The ADSs and warrants were ...
Breaking Medicine Technology: